Europe Agrees to Return Millions of Imported Johnson & Johnson Vaccines to Africa – Activists Claim Victory 03/09/2021 Kerry Cullinan European Commission head Ursula von der Leyen has agreed to return to Africa millions of Johnson & Johnson (J&J) COVID-19 vaccines that were imported from a South African manufacturer following a meeting with South Africa’s President Cyril Ramaphosa last week. This was revealed by African Union envoy Strive Masiyiwa said at an Africa Centres for […] Continue reading -> Johnson & Johnson Presents New Data to Support Booster for its COVID-19 Vaccine 26/08/2021 Kerry Cullinan Johnson & Johnson has joined other vaccine producers in advocating for a booster shot for its single-dose COVID-19 vaccine, which is being rolled out particularly in low-income African countries that had hoped to only vaccinate citizens once. The company made the announcement on Wednesday, following the results of interim data from two Phase 1/2a studies […] Continue reading -> FDA Orders Some 60 Million Johnson & Johnson Vaccines Made by Emergent to be Destroyed 11/06/2021 Kerry Cullinan The US Food and Drug Administration (FDA) has authorised the release of two batches of the Janssen/ Johnson & Johnson COVID-19 vaccine – about 10 million doses – manufactured at the Emergent BioSolutions facility in Baltimore, according to a statement on Friday. However, it also “determined several other batches are not suitable for use” while […] Continue reading -> Company Pushes Canada to Grant Compulsory License for Johnson & Johnson COVID-19 Vaccine 11/05/2021 Kerry Cullinan A Canadian pharmaceutical company, Biolyse, has agreed to provide Bolivia with 15 million doses of the Johnson & Johnson COVID-19 vaccine – as long as the Canadian government gives it a compulsory license to manufacture the vaccine. In March, Johnson & Johnson rejected an application by Biolyse for a voluntary license to make a generic […] Continue reading -> European Medicines Agency Reaffirms Benefits Of Johnson & Johnson Vaccine 21/04/2021 Chandre Prince There is a “possible link” between the Johnson & Johnson COVID-19 vaccine and very rare cases of blood clots, but the benefits of the single-dose vaccine outweigh the risks, the European Medicines Agency (EMA) has announced. In a statement released on Tuesday, the EMA safety committee said that the rare, but serious blood clot disorders, […] Continue reading -> United States Recommends ‘Pause’ In Johnson & Johnson COVID-19 Vaccine 13/04/2021 Raisa Santos The United States’ Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) have recommended a “pause” in administration of Johnson & Johnson’s (J&J) single-dose COVID-19 vaccine out of an “abundance of caution” following six cases of a rare type of blood clotting among the 6.8 million US recipients of the […] Continue reading -> EMA Reviews Link Between Blood Clots and Johnson & Johnson Vaccine 09/04/2021 Kerry Cullinan The European Medicines Agency is reviewing the cases of four people who developed blood clots after receiving Johnson & Johnson’s (J&J) COVID-19 vaccine, the regulator announced on Friday. “Four serious cases of unusual blood clots with low blood platelets have been reported post-vaccination with COVID-19 Vaccine Janssen. One case occurred in a clinical trial and […] Continue reading -> Nigeria Pivots From AstraZeneca To Johnson & Johnson COVID-19 Vaccine 31/03/2021 Paul Adepoju EXCLUSIVE – IBADAN – The Nigerian government has quietly ditched the AstraZeneca COVID-19 vaccine meant to vaccinate tens of millions of citizens, and will gradually shift to the Johnson & Johnson’s one-shot vaccine, saying it is easier to administer. Documents from the Nigerian Primary Healthcare Development Agency (NPHCDA) obtained by Health Policy Watch show […] Continue reading -> Johnson & Johnson Strikes Big Vaccine Deal With African Union – But Deliveries Only Begin In 3rd Quarter 2021 29/03/2021 Kerry Cullinan CAPE TOWN – Johnson & Johnson (J&J) will deliver its COVID-19 vaccine to Africa from October after reaching an agreement with the African Union to supply the continent with up to 400 million doses over the next two years. However, Africa may still be struggling to obtain vaccine supplies for some months following last week’s decision […] Continue reading -> As European Medicines Agency Approves One-Shot Johnson & Johnson COVID Vaccine – US Has Surplus & Africa A Dearth of Doses 11/03/2021 Elaine Ruth Fletcher & Raisa Santos With the European Union Medicines Agency (EMA) approval Thursday of Johnson and Johnson’s one-shot COVID-19 vaccine, it now remains to be seen which countries and regions will be the first in line for distribution of the one-jab vaccine. Along with its comparatively low-cost, and ease of storage, the one-shot vaccine could be particularly important to […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Johnson & Johnson Presents New Data to Support Booster for its COVID-19 Vaccine 26/08/2021 Kerry Cullinan Johnson & Johnson has joined other vaccine producers in advocating for a booster shot for its single-dose COVID-19 vaccine, which is being rolled out particularly in low-income African countries that had hoped to only vaccinate citizens once. The company made the announcement on Wednesday, following the results of interim data from two Phase 1/2a studies […] Continue reading -> FDA Orders Some 60 Million Johnson & Johnson Vaccines Made by Emergent to be Destroyed 11/06/2021 Kerry Cullinan The US Food and Drug Administration (FDA) has authorised the release of two batches of the Janssen/ Johnson & Johnson COVID-19 vaccine – about 10 million doses – manufactured at the Emergent BioSolutions facility in Baltimore, according to a statement on Friday. However, it also “determined several other batches are not suitable for use” while […] Continue reading -> Company Pushes Canada to Grant Compulsory License for Johnson & Johnson COVID-19 Vaccine 11/05/2021 Kerry Cullinan A Canadian pharmaceutical company, Biolyse, has agreed to provide Bolivia with 15 million doses of the Johnson & Johnson COVID-19 vaccine – as long as the Canadian government gives it a compulsory license to manufacture the vaccine. In March, Johnson & Johnson rejected an application by Biolyse for a voluntary license to make a generic […] Continue reading -> European Medicines Agency Reaffirms Benefits Of Johnson & Johnson Vaccine 21/04/2021 Chandre Prince There is a “possible link” between the Johnson & Johnson COVID-19 vaccine and very rare cases of blood clots, but the benefits of the single-dose vaccine outweigh the risks, the European Medicines Agency (EMA) has announced. In a statement released on Tuesday, the EMA safety committee said that the rare, but serious blood clot disorders, […] Continue reading -> United States Recommends ‘Pause’ In Johnson & Johnson COVID-19 Vaccine 13/04/2021 Raisa Santos The United States’ Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) have recommended a “pause” in administration of Johnson & Johnson’s (J&J) single-dose COVID-19 vaccine out of an “abundance of caution” following six cases of a rare type of blood clotting among the 6.8 million US recipients of the […] Continue reading -> EMA Reviews Link Between Blood Clots and Johnson & Johnson Vaccine 09/04/2021 Kerry Cullinan The European Medicines Agency is reviewing the cases of four people who developed blood clots after receiving Johnson & Johnson’s (J&J) COVID-19 vaccine, the regulator announced on Friday. “Four serious cases of unusual blood clots with low blood platelets have been reported post-vaccination with COVID-19 Vaccine Janssen. One case occurred in a clinical trial and […] Continue reading -> Nigeria Pivots From AstraZeneca To Johnson & Johnson COVID-19 Vaccine 31/03/2021 Paul Adepoju EXCLUSIVE – IBADAN – The Nigerian government has quietly ditched the AstraZeneca COVID-19 vaccine meant to vaccinate tens of millions of citizens, and will gradually shift to the Johnson & Johnson’s one-shot vaccine, saying it is easier to administer. Documents from the Nigerian Primary Healthcare Development Agency (NPHCDA) obtained by Health Policy Watch show […] Continue reading -> Johnson & Johnson Strikes Big Vaccine Deal With African Union – But Deliveries Only Begin In 3rd Quarter 2021 29/03/2021 Kerry Cullinan CAPE TOWN – Johnson & Johnson (J&J) will deliver its COVID-19 vaccine to Africa from October after reaching an agreement with the African Union to supply the continent with up to 400 million doses over the next two years. However, Africa may still be struggling to obtain vaccine supplies for some months following last week’s decision […] Continue reading -> As European Medicines Agency Approves One-Shot Johnson & Johnson COVID Vaccine – US Has Surplus & Africa A Dearth of Doses 11/03/2021 Elaine Ruth Fletcher & Raisa Santos With the European Union Medicines Agency (EMA) approval Thursday of Johnson and Johnson’s one-shot COVID-19 vaccine, it now remains to be seen which countries and regions will be the first in line for distribution of the one-jab vaccine. Along with its comparatively low-cost, and ease of storage, the one-shot vaccine could be particularly important to […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
FDA Orders Some 60 Million Johnson & Johnson Vaccines Made by Emergent to be Destroyed 11/06/2021 Kerry Cullinan The US Food and Drug Administration (FDA) has authorised the release of two batches of the Janssen/ Johnson & Johnson COVID-19 vaccine – about 10 million doses – manufactured at the Emergent BioSolutions facility in Baltimore, according to a statement on Friday. However, it also “determined several other batches are not suitable for use” while […] Continue reading -> Company Pushes Canada to Grant Compulsory License for Johnson & Johnson COVID-19 Vaccine 11/05/2021 Kerry Cullinan A Canadian pharmaceutical company, Biolyse, has agreed to provide Bolivia with 15 million doses of the Johnson & Johnson COVID-19 vaccine – as long as the Canadian government gives it a compulsory license to manufacture the vaccine. In March, Johnson & Johnson rejected an application by Biolyse for a voluntary license to make a generic […] Continue reading -> European Medicines Agency Reaffirms Benefits Of Johnson & Johnson Vaccine 21/04/2021 Chandre Prince There is a “possible link” between the Johnson & Johnson COVID-19 vaccine and very rare cases of blood clots, but the benefits of the single-dose vaccine outweigh the risks, the European Medicines Agency (EMA) has announced. In a statement released on Tuesday, the EMA safety committee said that the rare, but serious blood clot disorders, […] Continue reading -> United States Recommends ‘Pause’ In Johnson & Johnson COVID-19 Vaccine 13/04/2021 Raisa Santos The United States’ Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) have recommended a “pause” in administration of Johnson & Johnson’s (J&J) single-dose COVID-19 vaccine out of an “abundance of caution” following six cases of a rare type of blood clotting among the 6.8 million US recipients of the […] Continue reading -> EMA Reviews Link Between Blood Clots and Johnson & Johnson Vaccine 09/04/2021 Kerry Cullinan The European Medicines Agency is reviewing the cases of four people who developed blood clots after receiving Johnson & Johnson’s (J&J) COVID-19 vaccine, the regulator announced on Friday. “Four serious cases of unusual blood clots with low blood platelets have been reported post-vaccination with COVID-19 Vaccine Janssen. One case occurred in a clinical trial and […] Continue reading -> Nigeria Pivots From AstraZeneca To Johnson & Johnson COVID-19 Vaccine 31/03/2021 Paul Adepoju EXCLUSIVE – IBADAN – The Nigerian government has quietly ditched the AstraZeneca COVID-19 vaccine meant to vaccinate tens of millions of citizens, and will gradually shift to the Johnson & Johnson’s one-shot vaccine, saying it is easier to administer. Documents from the Nigerian Primary Healthcare Development Agency (NPHCDA) obtained by Health Policy Watch show […] Continue reading -> Johnson & Johnson Strikes Big Vaccine Deal With African Union – But Deliveries Only Begin In 3rd Quarter 2021 29/03/2021 Kerry Cullinan CAPE TOWN – Johnson & Johnson (J&J) will deliver its COVID-19 vaccine to Africa from October after reaching an agreement with the African Union to supply the continent with up to 400 million doses over the next two years. However, Africa may still be struggling to obtain vaccine supplies for some months following last week’s decision […] Continue reading -> As European Medicines Agency Approves One-Shot Johnson & Johnson COVID Vaccine – US Has Surplus & Africa A Dearth of Doses 11/03/2021 Elaine Ruth Fletcher & Raisa Santos With the European Union Medicines Agency (EMA) approval Thursday of Johnson and Johnson’s one-shot COVID-19 vaccine, it now remains to be seen which countries and regions will be the first in line for distribution of the one-jab vaccine. Along with its comparatively low-cost, and ease of storage, the one-shot vaccine could be particularly important to […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Company Pushes Canada to Grant Compulsory License for Johnson & Johnson COVID-19 Vaccine 11/05/2021 Kerry Cullinan A Canadian pharmaceutical company, Biolyse, has agreed to provide Bolivia with 15 million doses of the Johnson & Johnson COVID-19 vaccine – as long as the Canadian government gives it a compulsory license to manufacture the vaccine. In March, Johnson & Johnson rejected an application by Biolyse for a voluntary license to make a generic […] Continue reading -> European Medicines Agency Reaffirms Benefits Of Johnson & Johnson Vaccine 21/04/2021 Chandre Prince There is a “possible link” between the Johnson & Johnson COVID-19 vaccine and very rare cases of blood clots, but the benefits of the single-dose vaccine outweigh the risks, the European Medicines Agency (EMA) has announced. In a statement released on Tuesday, the EMA safety committee said that the rare, but serious blood clot disorders, […] Continue reading -> United States Recommends ‘Pause’ In Johnson & Johnson COVID-19 Vaccine 13/04/2021 Raisa Santos The United States’ Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) have recommended a “pause” in administration of Johnson & Johnson’s (J&J) single-dose COVID-19 vaccine out of an “abundance of caution” following six cases of a rare type of blood clotting among the 6.8 million US recipients of the […] Continue reading -> EMA Reviews Link Between Blood Clots and Johnson & Johnson Vaccine 09/04/2021 Kerry Cullinan The European Medicines Agency is reviewing the cases of four people who developed blood clots after receiving Johnson & Johnson’s (J&J) COVID-19 vaccine, the regulator announced on Friday. “Four serious cases of unusual blood clots with low blood platelets have been reported post-vaccination with COVID-19 Vaccine Janssen. One case occurred in a clinical trial and […] Continue reading -> Nigeria Pivots From AstraZeneca To Johnson & Johnson COVID-19 Vaccine 31/03/2021 Paul Adepoju EXCLUSIVE – IBADAN – The Nigerian government has quietly ditched the AstraZeneca COVID-19 vaccine meant to vaccinate tens of millions of citizens, and will gradually shift to the Johnson & Johnson’s one-shot vaccine, saying it is easier to administer. Documents from the Nigerian Primary Healthcare Development Agency (NPHCDA) obtained by Health Policy Watch show […] Continue reading -> Johnson & Johnson Strikes Big Vaccine Deal With African Union – But Deliveries Only Begin In 3rd Quarter 2021 29/03/2021 Kerry Cullinan CAPE TOWN – Johnson & Johnson (J&J) will deliver its COVID-19 vaccine to Africa from October after reaching an agreement with the African Union to supply the continent with up to 400 million doses over the next two years. However, Africa may still be struggling to obtain vaccine supplies for some months following last week’s decision […] Continue reading -> As European Medicines Agency Approves One-Shot Johnson & Johnson COVID Vaccine – US Has Surplus & Africa A Dearth of Doses 11/03/2021 Elaine Ruth Fletcher & Raisa Santos With the European Union Medicines Agency (EMA) approval Thursday of Johnson and Johnson’s one-shot COVID-19 vaccine, it now remains to be seen which countries and regions will be the first in line for distribution of the one-jab vaccine. Along with its comparatively low-cost, and ease of storage, the one-shot vaccine could be particularly important to […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
European Medicines Agency Reaffirms Benefits Of Johnson & Johnson Vaccine 21/04/2021 Chandre Prince There is a “possible link” between the Johnson & Johnson COVID-19 vaccine and very rare cases of blood clots, but the benefits of the single-dose vaccine outweigh the risks, the European Medicines Agency (EMA) has announced. In a statement released on Tuesday, the EMA safety committee said that the rare, but serious blood clot disorders, […] Continue reading -> United States Recommends ‘Pause’ In Johnson & Johnson COVID-19 Vaccine 13/04/2021 Raisa Santos The United States’ Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) have recommended a “pause” in administration of Johnson & Johnson’s (J&J) single-dose COVID-19 vaccine out of an “abundance of caution” following six cases of a rare type of blood clotting among the 6.8 million US recipients of the […] Continue reading -> EMA Reviews Link Between Blood Clots and Johnson & Johnson Vaccine 09/04/2021 Kerry Cullinan The European Medicines Agency is reviewing the cases of four people who developed blood clots after receiving Johnson & Johnson’s (J&J) COVID-19 vaccine, the regulator announced on Friday. “Four serious cases of unusual blood clots with low blood platelets have been reported post-vaccination with COVID-19 Vaccine Janssen. One case occurred in a clinical trial and […] Continue reading -> Nigeria Pivots From AstraZeneca To Johnson & Johnson COVID-19 Vaccine 31/03/2021 Paul Adepoju EXCLUSIVE – IBADAN – The Nigerian government has quietly ditched the AstraZeneca COVID-19 vaccine meant to vaccinate tens of millions of citizens, and will gradually shift to the Johnson & Johnson’s one-shot vaccine, saying it is easier to administer. Documents from the Nigerian Primary Healthcare Development Agency (NPHCDA) obtained by Health Policy Watch show […] Continue reading -> Johnson & Johnson Strikes Big Vaccine Deal With African Union – But Deliveries Only Begin In 3rd Quarter 2021 29/03/2021 Kerry Cullinan CAPE TOWN – Johnson & Johnson (J&J) will deliver its COVID-19 vaccine to Africa from October after reaching an agreement with the African Union to supply the continent with up to 400 million doses over the next two years. However, Africa may still be struggling to obtain vaccine supplies for some months following last week’s decision […] Continue reading -> As European Medicines Agency Approves One-Shot Johnson & Johnson COVID Vaccine – US Has Surplus & Africa A Dearth of Doses 11/03/2021 Elaine Ruth Fletcher & Raisa Santos With the European Union Medicines Agency (EMA) approval Thursday of Johnson and Johnson’s one-shot COVID-19 vaccine, it now remains to be seen which countries and regions will be the first in line for distribution of the one-jab vaccine. Along with its comparatively low-cost, and ease of storage, the one-shot vaccine could be particularly important to […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
United States Recommends ‘Pause’ In Johnson & Johnson COVID-19 Vaccine 13/04/2021 Raisa Santos The United States’ Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) have recommended a “pause” in administration of Johnson & Johnson’s (J&J) single-dose COVID-19 vaccine out of an “abundance of caution” following six cases of a rare type of blood clotting among the 6.8 million US recipients of the […] Continue reading -> EMA Reviews Link Between Blood Clots and Johnson & Johnson Vaccine 09/04/2021 Kerry Cullinan The European Medicines Agency is reviewing the cases of four people who developed blood clots after receiving Johnson & Johnson’s (J&J) COVID-19 vaccine, the regulator announced on Friday. “Four serious cases of unusual blood clots with low blood platelets have been reported post-vaccination with COVID-19 Vaccine Janssen. One case occurred in a clinical trial and […] Continue reading -> Nigeria Pivots From AstraZeneca To Johnson & Johnson COVID-19 Vaccine 31/03/2021 Paul Adepoju EXCLUSIVE – IBADAN – The Nigerian government has quietly ditched the AstraZeneca COVID-19 vaccine meant to vaccinate tens of millions of citizens, and will gradually shift to the Johnson & Johnson’s one-shot vaccine, saying it is easier to administer. Documents from the Nigerian Primary Healthcare Development Agency (NPHCDA) obtained by Health Policy Watch show […] Continue reading -> Johnson & Johnson Strikes Big Vaccine Deal With African Union – But Deliveries Only Begin In 3rd Quarter 2021 29/03/2021 Kerry Cullinan CAPE TOWN – Johnson & Johnson (J&J) will deliver its COVID-19 vaccine to Africa from October after reaching an agreement with the African Union to supply the continent with up to 400 million doses over the next two years. However, Africa may still be struggling to obtain vaccine supplies for some months following last week’s decision […] Continue reading -> As European Medicines Agency Approves One-Shot Johnson & Johnson COVID Vaccine – US Has Surplus & Africa A Dearth of Doses 11/03/2021 Elaine Ruth Fletcher & Raisa Santos With the European Union Medicines Agency (EMA) approval Thursday of Johnson and Johnson’s one-shot COVID-19 vaccine, it now remains to be seen which countries and regions will be the first in line for distribution of the one-jab vaccine. Along with its comparatively low-cost, and ease of storage, the one-shot vaccine could be particularly important to […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
EMA Reviews Link Between Blood Clots and Johnson & Johnson Vaccine 09/04/2021 Kerry Cullinan The European Medicines Agency is reviewing the cases of four people who developed blood clots after receiving Johnson & Johnson’s (J&J) COVID-19 vaccine, the regulator announced on Friday. “Four serious cases of unusual blood clots with low blood platelets have been reported post-vaccination with COVID-19 Vaccine Janssen. One case occurred in a clinical trial and […] Continue reading -> Nigeria Pivots From AstraZeneca To Johnson & Johnson COVID-19 Vaccine 31/03/2021 Paul Adepoju EXCLUSIVE – IBADAN – The Nigerian government has quietly ditched the AstraZeneca COVID-19 vaccine meant to vaccinate tens of millions of citizens, and will gradually shift to the Johnson & Johnson’s one-shot vaccine, saying it is easier to administer. Documents from the Nigerian Primary Healthcare Development Agency (NPHCDA) obtained by Health Policy Watch show […] Continue reading -> Johnson & Johnson Strikes Big Vaccine Deal With African Union – But Deliveries Only Begin In 3rd Quarter 2021 29/03/2021 Kerry Cullinan CAPE TOWN – Johnson & Johnson (J&J) will deliver its COVID-19 vaccine to Africa from October after reaching an agreement with the African Union to supply the continent with up to 400 million doses over the next two years. However, Africa may still be struggling to obtain vaccine supplies for some months following last week’s decision […] Continue reading -> As European Medicines Agency Approves One-Shot Johnson & Johnson COVID Vaccine – US Has Surplus & Africa A Dearth of Doses 11/03/2021 Elaine Ruth Fletcher & Raisa Santos With the European Union Medicines Agency (EMA) approval Thursday of Johnson and Johnson’s one-shot COVID-19 vaccine, it now remains to be seen which countries and regions will be the first in line for distribution of the one-jab vaccine. Along with its comparatively low-cost, and ease of storage, the one-shot vaccine could be particularly important to […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Nigeria Pivots From AstraZeneca To Johnson & Johnson COVID-19 Vaccine 31/03/2021 Paul Adepoju EXCLUSIVE – IBADAN – The Nigerian government has quietly ditched the AstraZeneca COVID-19 vaccine meant to vaccinate tens of millions of citizens, and will gradually shift to the Johnson & Johnson’s one-shot vaccine, saying it is easier to administer. Documents from the Nigerian Primary Healthcare Development Agency (NPHCDA) obtained by Health Policy Watch show […] Continue reading -> Johnson & Johnson Strikes Big Vaccine Deal With African Union – But Deliveries Only Begin In 3rd Quarter 2021 29/03/2021 Kerry Cullinan CAPE TOWN – Johnson & Johnson (J&J) will deliver its COVID-19 vaccine to Africa from October after reaching an agreement with the African Union to supply the continent with up to 400 million doses over the next two years. However, Africa may still be struggling to obtain vaccine supplies for some months following last week’s decision […] Continue reading -> As European Medicines Agency Approves One-Shot Johnson & Johnson COVID Vaccine – US Has Surplus & Africa A Dearth of Doses 11/03/2021 Elaine Ruth Fletcher & Raisa Santos With the European Union Medicines Agency (EMA) approval Thursday of Johnson and Johnson’s one-shot COVID-19 vaccine, it now remains to be seen which countries and regions will be the first in line for distribution of the one-jab vaccine. Along with its comparatively low-cost, and ease of storage, the one-shot vaccine could be particularly important to […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Johnson & Johnson Strikes Big Vaccine Deal With African Union – But Deliveries Only Begin In 3rd Quarter 2021 29/03/2021 Kerry Cullinan CAPE TOWN – Johnson & Johnson (J&J) will deliver its COVID-19 vaccine to Africa from October after reaching an agreement with the African Union to supply the continent with up to 400 million doses over the next two years. However, Africa may still be struggling to obtain vaccine supplies for some months following last week’s decision […] Continue reading -> As European Medicines Agency Approves One-Shot Johnson & Johnson COVID Vaccine – US Has Surplus & Africa A Dearth of Doses 11/03/2021 Elaine Ruth Fletcher & Raisa Santos With the European Union Medicines Agency (EMA) approval Thursday of Johnson and Johnson’s one-shot COVID-19 vaccine, it now remains to be seen which countries and regions will be the first in line for distribution of the one-jab vaccine. Along with its comparatively low-cost, and ease of storage, the one-shot vaccine could be particularly important to […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
As European Medicines Agency Approves One-Shot Johnson & Johnson COVID Vaccine – US Has Surplus & Africa A Dearth of Doses 11/03/2021 Elaine Ruth Fletcher & Raisa Santos With the European Union Medicines Agency (EMA) approval Thursday of Johnson and Johnson’s one-shot COVID-19 vaccine, it now remains to be seen which countries and regions will be the first in line for distribution of the one-jab vaccine. Along with its comparatively low-cost, and ease of storage, the one-shot vaccine could be particularly important to […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy